Get started
Author

Hesham Mourad

Observed name: H. Mourad
Institution: Mayo Clinic
ORCID: 0000-0002-5611-3261
Observed ORCID: 0000-0002-5611-3261
OpenAlex ID: A5022187028
ASHP Statement on Telehealth Pharmacy Practice
2022 · Brendan R Begnoche, C David Butler, et al. · American Journal of Health-System Pharmacy · 15
ASHP Guidelines on the Safe Use of Automated Compounding Devices for the Preparation of Parenteral Nutrition Admixtures
2022 · Benjamin Iredell, Hesham Mourad, et al. · American Journal of Health-System Pharmacy · 15
Safety and Efficacy of FOLFOX Followed by Cetuximab for Metastatic Colorectal Cancer With Severe Liver Dysfunction
2014 · Raymond Elsoueidi, Jessica Craig, et al. · Journal of the National Comprehensive Cancer Network · 11
PDF
Culturally Competent Oncology Care for Muslim Patients: A Case-Based Narrative Review of Barriers and Clinical Outcomes
2026 · Omar Alkhabbaz, Asim Mohamed, et al. · Cureus · 2
PDF
Chemotherapy dosing in achondroplastic dwarfism: a case report and review of literature
2016 · R. Elsoueidi, C. Gresham, et al. · Journal of Clinical Pharmacy and Therapeutics · 2
PDF
Bendamustine treatment in a heavily pretreated Hodgkin lymphoma patient
2014 · Raymond Elsoueidi, Alem Mulat, et al. · Journal of Oncology Pharmacy Practice · 1
430: Reduction of Inappropriate Proton Pump Inhibitor Use in a Mixed Intensive Care Unit
2018 · Sarah Peacock, Hesham Mourad, et al. · Critical Care Medicine
Bendamustine for refractory Hodgkin?s lymphoma, is it good enough?
2014 · Hesham Mourad · Journal of Cancer Science & Therapy
Works count: 8
Citation count: 46
H-index: 3
I10-index: 3
Year
Topic
Type